Only the interaction of Lrp1 C766T polymorphism with other genes involved in AD pathogenesis, such as APOE and MAPT (microtubule associated protein tau), has been reported to be a risk factor for AD predisposition [152,153,154,155,156]. The gene discussed is MAPT; the disease is Alzheimer disease.